GROGAN DONNA ROY — SEC insider filings

SEC reporting owner CIK 1788455. 23 insider filings on record with FilingPulse; latest filed 2026-10-02.

Transaction summary — filings shown

Covers all 23 filings on record, filed 2020-10-01 to 2026-10-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
C4 Therapeutics, Inc. (CCCC)Director22——22
MOMENTA PHARMACEUTICALS INC (MNTA)Director1——2

Insider filings — GROGAN DONNA ROY

FiledFormIssuerReported transactionsSource
2026-10-024C4 Therapeutics, Inc. (CCCC)Grant/award (A): 4,618 @ $3.14EDGAR
2026-07-024C4 Therapeutics, Inc. (CCCC)Grant/award (A): 3,341 @ $4.34EDGAR
2026-06-264C4 Therapeutics, Inc. (CCCC)Grant/award (A): 62,000 (derivative) @ $0EDGAR
2026-04-034C4 Therapeutics, Inc. (CCCC)Grant/award (A): 5,370 @ $2.70EDGAR
2026-01-054C4 Therapeutics, Inc. (CCCC)Grant/award (A): 7,513 @ $1.93EDGAR
2025-10-034C4 Therapeutics, Inc. (CCCC)Grant/award (A): 6,740 @ $2.15EDGAR
2025-07-024C4 Therapeutics, Inc. (CCCC)Grant/award (A): 9,609 @ $1.51EDGAR
2025-06-204C4 Therapeutics, Inc. (CCCC)Grant/award (A): 35,500 (derivative) @ $0EDGAR
2025-04-034C4 Therapeutics, Inc. (CCCC)Grant/award (A): 9,581 @ $1.44EDGAR
2025-01-034C4 Therapeutics, Inc. (CCCC)Grant/award (A): 3,757 @ $3.66EDGAR
2024-10-024C4 Therapeutics, Inc. (CCCC)Grant/award (A): 2,474 @ $5.56EDGAR
2024-07-024C4 Therapeutics, Inc. (CCCC)Grant/award (A): 2,836 @ $4.85EDGAR
2024-06-214C4 Therapeutics, Inc. (CCCC)Grant/award (A): 32,500 (derivative) @ $0EDGAR
2024-04-024C4 Therapeutics, Inc. (CCCC)Grant/award (A): 1,697 @ $8.10EDGAR
2024-01-034C4 Therapeutics, Inc. (CCCC)Grant/award (A): 2,108 @ $6.52EDGAR
2023-10-034C4 Therapeutics, Inc. (CCCC)Grant/award (A): 8,089 @ $1.70EDGAR
2023-07-054C4 Therapeutics, Inc. (CCCC)Grant/award (A): 4,858 @ $2.83EDGAR
2023-06-164C4 Therapeutics, Inc. (CCCC)Grant/award (A): 26,000 (derivative) @ $0EDGAR
2023-04-044C4 Therapeutics, Inc. (CCCC)Grant/award (A): 4,298 @ $3.20EDGAR
2023-01-044C4 Therapeutics, Inc. (CCCC)Grant/award (A): 1,763 @ $6.38EDGAR
2022-10-044C4 Therapeutics, Inc. (CCCC)Grant/award (A): 819 @ $8.69EDGAR
2022-08-024C4 Therapeutics, Inc. (CCCC)Grant/award (A): 41,200 (derivative) @ $0EDGAR
2020-10-014MOMENTA PHARMACEUTICALS INC (MNTA)Disposition to issuer (D): 50,000 (derivative) · Disposition to issuer (D): 25,000 (derivative)EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-09-28 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1788455 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs